113 related articles for article (PubMed ID: 6547433)
1. Isolation, drug sensitivity, and some biochemical and genetical properties of macromomycin-resistant mouse lymphoblastoma L5178Y cells.
Suzuki H; Sugimoto Y; Tanaka K; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1984 May; 37(5):602-9. PubMed ID: 6547433
[TBL] [Abstract][Full Text] [Related]
2. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
4. Alteration of membrane-associated enzymes in drug-resistant sublines of mouse lymphoblastoma L5178Y cells.
Sugimoto Y; Nishimura T; Suzuki H; Tanaka N
J Antibiot (Tokyo); 1981 Sep; 34(9):1200-5. PubMed ID: 6173369
[TBL] [Abstract][Full Text] [Related]
5. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.
Nishimura T; Suzuki H; Muto K; Tanaka N
J Antibiot (Tokyo); 1979 May; 32(5):518-22. PubMed ID: 583339
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of action and resistance of antineoplastic agents].
Tanaka N
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
[TBL] [Abstract][Full Text] [Related]
8. Drug sensitivity and some characteristics of a bleomycin-resistant subline of mouse lymphoblastoma L5178Y cells.
Suzuki H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1981 Sep; 34(9):1210-2. PubMed ID: 6173370
[No Abstract] [Full Text] [Related]
9. Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.
Sugimoto Y; Suzuki H; Yamaki H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1982 Sep; 35(9):1222-30. PubMed ID: 7142023
[TBL] [Abstract][Full Text] [Related]
10. Alteration of plasma membrane of drug-resistant tumor cells: 230-kilodalton protein identified by monoclonal antibody.
Sugimoto Y; Suzuki H; Tanaka N
Biochem Biophys Res Commun; 1983 Aug; 114(3):969-75. PubMed ID: 6577861
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of macromomycin].
Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of macromomycin: DNA strand scission, inhibition of DNA synthesis and mitosis.
Suzuki H; Nishimura T; Muto K; Tanaka N
J Antibiot (Tokyo); 1978 Sep; 31(9):875-83. PubMed ID: 711629
[TBL] [Abstract][Full Text] [Related]
13. DNA strand scission in vivo and in vitro by auromomycin.
Suzuki H; Nishimura T; Tanaka N
Cancer Res; 1979 Jul; 39(7 Pt 1):2787-91. PubMed ID: 445483
[TBL] [Abstract][Full Text] [Related]
14. Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line.
Giavazzi R; Scholar E; Hart IR
Cancer Res; 1983 May; 43(5):2216-22. PubMed ID: 6831444
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of macromomycin.
Hidaka T; Yano Y; Yamashita T; Watanabe K
J Antibiot (Tokyo); 1979 Apr; 32(4):340-6. PubMed ID: 468721
[TBL] [Abstract][Full Text] [Related]
16. Drug sensitivity of an adriamycin-resistant mutant subline of mouse lymphoblastoma L5178Y cells.
Nishimura T; Muto K; Tanaka N
J Antibiot (Tokyo); 1978 May; 31(5):493-5. PubMed ID: 670093
[No Abstract] [Full Text] [Related]
17. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.
Kunimoto S; Miura K; Umezawa K; Xu CZ; Masuda T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1984 Dec; 37(12):1697-702. PubMed ID: 6526737
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro.
Miyamoto Y; Oda T; Maeda H
Cancer Res; 1990 Mar; 50(5):1571-5. PubMed ID: 2137371
[TBL] [Abstract][Full Text] [Related]
19. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
